04/03/2018

Recent Oncology Related Drug News

NCCN Guide for Immunotherapy Adverse Events

(Medscape Medical News) Mar 29, 2018 - Some of the side effects of immunotherapies for cancer become very serious, very fast. The National Comprehensive Cancer Network (NCCN) now has an easy-to-use guideline for that.  READ ARTICLE (free registration required)

House Subcommittee Urged to Consider Solution to Step Therapy

March 19, 2018 - In a letter to the Committee on Education and the Workforce Subcommittee on Health, Employment, Labor and Pensions leadership, ASCO and 25 other healthcare groups asked the House Subcommittee to consider the Restoring the Patients Voice Act of 2017 (H.R. 2077).  This legislation, which has bipartisan support from 28 lawmakers, provides patient protections against step therapy protocols imposed by private sector health plans.  READ MORE

The Uncertain State of the 340B Program: Where Are We Now?

In January 2018, in the wake of the publication of the House Energy and Commerce Committee’s Review of the 340B Drug Discount Program, I wrote that it was too soon to know whether 2018 will be a game-changing year for the 340B Program. In sum, there were just too many moving parts to discern whether there was a path forward for legislative change.  READ MORE